Endoscopic mucosal resection GASTROINTESTINAL ENDOSCOPY Hwang, J. H., Konda, V., Abu Dayyeh, B. K., Chauhan, S. S., Enestvedt, B. K., Fujii-Lau, L. L., Komanduri, S., Maple, J. T., Murad, F. M., Pannala, R., Thosani, N. C., Banerjee, S. 2015; 82 (2): 215-226

Abstract

EMR has become an established therapeutic option for premalignant and early-stage GI malignancies, particularly in the esophagus and colon. EMR can also aid in the diagnosis and therapy of subepithelial lesions localized to the muscularis mucosa or submucosa. Several dedicated EMR devices are available to facilitate these procedures. Adverse event rates, particularly bleeding and perforation, are higher after EMR relative to other basic endoscopic interventions but lower than adverse event rates for ESD. Endoscopists performing EMR should be knowledgeable and skilled in managing potential adverse events resulting from EMR.

View details for DOI 10.1016/j.gie.2015.05.001

View details for Web of Science ID 000357898100003

View details for PubMedID 26077453